T Fang, X Cao, B Shen, Z Chen,
G Chen - Biomaterials, 2023 - Elsevier
Despite the promise of immune checkpoint blockade (ICB) for cancer treatment, challenges
associated with this therapy still exist, including low response rates and severe side effects …